COVLINIC Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for COVLINIC with the United States Patent and Trademark Office. The USPTO has given the COVLINIC trademark a serial number of 88895897. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 12, 2021. This trademark is owned by Pfizer Inc.. The COVLINIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
covlinic

General Information

Serial Number88895897
Word MarkCOVLINIC
Filing DateThursday, April 30, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, May 12, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 12, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Thursday, October 22, 2020ASSIGNED TO EXAMINER
Wednesday, May 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 4, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

covlinic preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone